Differential Effects of Sacubitril/Valsartan on Diastolic Function in Mice With Obesity-Related Metabolic Heart Disease

por Croteau, Dominique, Qin, Fuzhong, Chambers, Jordan M., Kallick, Ethan, Luptak, Ivan, Panagia, Marcello, Pimentel, David R., Siwik, Deborah A., Colucci, Wilson S.
Publicado 2020

Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Dia...

por Croteau, Dominique, Luptak, Ivan, Chambers, Jordan M., Hobai, Ion, Panagia, Marcello, Pimentel, David R., Siwik, Deborah A., Qin, Fuzhong, Colucci, Wilson S.
Publicado 2021

SGLT2 inhibitor ertugliflozin decreases elevated intracellular sodium, and improves energetics and contractile function in diabetic cardiomyopathy

por Croteau, Dominique, Baka, Tomas, Young, Sara, He, Huamei, Chambers, Jordan M., Qin, Fuzhong, Panagia, Marcello, Pimentel, David R., Balschi, James A., Colucci, Wilson S., Luptak, Ivan
Publicado 2023